Genetic testing identified deleterious variants in ATP1A3, TSC1, KPNA7, DOCK7, and DIAPH1 (Table 1, Invitae [San Franciso, CA, USA] Epilepsy and Dystonia Panels). This evidence concerns the gene ATP1A3 and epilepsy.